Induction therapy with PD-1 antibody combined with platinum-based doublet chemotherapy for locally-advanced non-small cell lung cancer: A randomised controlled, open-label, phase 2 trial

被引：0
|
作者：
Wang, Suyu [1 ]
Zhang, Peng [1 ]
机构：
[1] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Thorac Surg, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8044
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy of combined PD-1 immune therapy and chemotherapy in the treatment of locally advanced non-small cell lung cancer
    Li, Yongjie
    Fu, Dunzhi
    Li, Biao
    Zhou, Yuan
    Li, Fan
    Wang, Qiongyu
    Huang, Jialei
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (05) : 1065 - 1071
  • [2] Matrine promotes the efficacy and safety of platinum-based doublet chemotherapy for advanced non-small cell lung cancer
    Rong, Biaoxue
    Zhao, Chongchong
    Gao, Wenlong
    Yang, Shuanying
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (09): : 14701 - 14717
  • [3] AK112, a novel PD-1/VEGF bispecific antibody, in combination with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC): an open-label, multicenter, phase II trial
    Zhao, Yuanyuan
    Chen, Gang
    Chen, Jianhua
    Zhuang, Li
    Du, Yingying
    Yu, Qitao
    Zhuang, Wu
    Zhao, Yanqiu
    Zhou, Ming
    Zhang, Weidong
    Zhang, Yu
    Wan, Yixin
    Li, Wenting
    Song, Weifeng
    Wang, Zhongmin Maxwell
    Li, Baiyong
    Xia, Michelle
    Yang, Yunpeng
    Fang, Wenfeng
    Huang, Yan
    Zhang, Li
    ECLINICALMEDICINE, 2023, 62
  • [4] Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial
    Kato, Ken
    Machida, Ryunosuke
    Ito, Yoshinori
    Daiko, Hiroyuki
    Ozawa, Soji
    Ogata, Takashi
    Hara, Hiroki
    Kojima, Takashi
    Abe, Tetsuya
    Bamba, Takeo
    Watanabe, Masaya
    Kawakubo, Hirofumi
    Shibuya, Yuichi
    Tsubosa, Yasuhiro
    Takegawa, Naoki
    Kajiwara, Takeshi
    Baba, Hideo
    Ueno, Masaki
    Takeuchi, Hiroya
    Nakamura, Kenichi
    Kitagawa, Yuko
    LANCET, 2024, 404 (10447): : 55 - 66
  • [5] Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial
    Georgoulias, V
    Papadakis, E
    Alexopoulos, A
    Tsiafaki, X
    Rapti, A
    Veslemes, M
    Palamidas, P
    Vlachonikolis, I
    LANCET, 2001, 357 (9267): : 1478 - 1484
  • [6] Nivolumab as maintenance therapy following platinum-based chemotherapy in non-small cell lung cancer patients after tyrosine kinase inhibitor therapy: A single-arm, open-label, phase 2 trial
    Kim, Jiwon
    Ji, Wonjun
    Choi, Chang Min
    Lee, Jae Cheol
    RESPIROLOGY, 2023, 28 : 307 - 307
  • [7] XPG polymorphisms are associated with prognosis of advanced non-small cell lung cancer treated with platinum-based doublet chemotherapy
    Zou, H. Z.
    Zhao, Y. Q.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (01) : 500 - 506
  • [8] Iodine-125 Seeds Implantation Combined with PD-1 Inhibitor Plus Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer: A Retrospective Study
    Wang, Jingyi
    Sun, Lan
    Zhang, Yuanyuan
    Li, Xiaoqing
    Qiu, Dan
    MOLECULAR THERAPY, 2023, 31 (04) : 406 - 407
  • [9] Bevacizumab plus platinum-based chemotherapy in advanced non-squamous non-small-cell lung cancer: a randomized, open-label phase 2 study (CLEAR)
    Udagawa, Hibiki
    Sugiyama, Eri
    Harada, Toshiyuki
    Atagi, Shinji
    Koyama, Ryo
    Watanabe, Satoshi
    Nakamura, Yukiko
    Harada, Daijiro
    Hataji, Osamu
    Tanaka, Fumihiro
    Kida, Hiroshi
    Satouchi, Miyako
    Maeno, Ken
    Inoue, Akira
    Yoh, Kiyotaka
    Yamane, Yuki
    Urata, Yoshiko
    Yoshioka, Hiroshige
    Yamanaka, Takeharu
    Goto, Koichi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (07) : 3059 - +
  • [10] Bevacizumab Plus Platinum-Based Chemotherapy In Advanced Non-Small Cell Lung Cancer
    Wagstaff, Antona J.
    Keam, Susan J.
    McCormack, Paul L.
    BIODRUGS, 2009, 23 (03) : 187 - 196
12345